journal article·2026-11Open access

Immunity-and-matrix-regulatory cells promote hyaline-like cartilage repair in osteoarthritis

Yiqi Su, Zihao He, Kai Wang, Tingting Gao, Jiao Jiao Li, Qianqian Chen, Long Chen, Shasha Liu, Fanhao Ye, Jingzhou Wang, Shichun Xu, Du Wang, Zhen Yang, Zijin Zhou, Caiyi Wei, Jun Wu, Jianhao Lin, Hui Li, Dan Xing

Abstract

Articular cartilage repair in osteoarthritis (OA) remains a major clinical challenge. Although approaches using mesenchymal stem cells (MSCs) have demonstrated partial efficacy in OA, the regenerated tissue is often unable to form stable hyaline-like cartilage phenotype. Here, we introduce immunity-and-matrix-regulatory cells (IMRCs), derived from human embryonic stem cells (ESCs), as an alternative cell source for OA therapy. Using a multiple-level platform including 2D chondrocytes, 3D OA cartilage organoids (OCOs), rabbit cartilage explants, and a rat OA model, we demonstrate that IMRCs significantly enhance hyaline-like matrix formation while suppressing inflammation, angiogenesis, and fibrotic remodeling. Mechanistically, IMRC-mediated cartilage repair is partially associated with MMP1-dependent matrix remodeling. This study establishes a translational evaluation strategy for IMRCs and points to their potential as an alternative cell source for inducing cartilage repair in OA. Notably, the OCOs established in this study provide a pathologically relevant in vitro platform for evaluating cartilage regeneration in OA.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Immune responses and vaccinations · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (75)

Show source-provided references
1. Global prevalence, incidence, and years lived with disability (YLDs) of osteoarthritis: trends from 1990 to 2021 and projections to 2050
2. The immune microenvironment in cartilage injury and repair10.1016/j.actbio.2021.12.006 ↗
3. Regeneration of articular cartilage defects: therapeutic strategies and perspectives10.1177/20417314231164765 ↗
4. Osteoarthritis10.1038/nrdp.2016.72 ↗
5. Osteoarthritis as a systemic disease10.1038/s41584-025-01332-8 ↗
6. Advances in the pathology and treatment of osteoarthritis10.1016/j.jare.2025.01.053 ↗
7. Natural compounds and mesenchymal stem cells: implications for inflammatory-impaired tissue regeneration10.1186/s13287-024-03641-3 ↗
8. Intraarticular injections of mesenchymal stem cells in knee osteoarthritis: a review of their Current molecular mechanisms of action and their efficacy10.3390/ijms232314953 ↗
9. Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials10.1186/s13287-025-04252-2 ↗
10. Bone marrow mesenchymal stem cells overexpressing FGF-2 loaded onto a decellularized extracellular matrix hydrogel for the treatment of osteoarthritis10.1039/D5BM00920K ↗
11. Therapeutic efficacy of extracellular vesicles from hiPSC-derived MSCs in serum-containing and xeno-free media for osteoarthritis treatment10.1186/s13287-025-04890-6 ↗
12. Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stromal cells: preclinical development and first-in-human intra-articular validation as therapeutics for knee osteoarthritis10.1186/s12951-024-03088-x ↗
13. CytoplastCXCR4: an enucleated self-eliminating and mitochondria delivering strategy for targeted cartilage defect therapy10.1016/j.biomaterials.2026.124167 ↗
14. Tissue engineering strategies hold promise for the repair of articular cartilage injury10.1186/s12938-024-01260-w ↗
15. Stem cell-based cartilage regeneration: biological strategies, engineering innovations, and clinical translation
16. Articular fibrocartilage - why does hyaline cartilage fail to repair?10.1016/j.addr.2018.12.015 ↗
17. Mesenchymal stromal cells: heterogeneity and therapeutical applications10.3390/cells12162039 ↗
18. Mesenchymal stem cells in fibrotic diseases-the two sides of the same coin10.1038/s41401-022-00952-0 ↗
19. Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis10.1038/s41422-020-0354-1 ↗
20. The therapeutic effects of human embryonic stem cells-derived immunity-and-matrix regulatory cells on membranous nephropathy10.1186/s13287-022-02917-w ↗
21. Immunity-and-matrix-regulatory cells enhance cartilage regeneration for meniscus injuries: a phase I dose-escalation trial10.1038/s41392-023-01670-7 ↗
22. Optimized administration of human embryonic stem cell-derived immunity-and-matrix regulatory cells for mouse lung injury and fibrosis10.1186/s13287-024-03945-4 ↗
23. Human embryonic stem cell-derived immunity-and-matrix-regulatory cells promote endometrial repair and fertility restoration in IUA rats10.1186/s13287-025-04298-2 ↗
24. Organogenesis in a dish: modeling development and disease using organoid technologies10.1126/science.1247125 ↗
25. Stem cell-derived organoids as a next-generation platform for drug toxicity and efficacy testing: toward replacing animal models in regulatory science10.1002/jat.70059 ↗
26. A review of advanced biomaterials and cells for the production of bone organoid10.1002/smsc.202300027 ↗
27. Engineering bone/cartilage organoids: strategy, progress, and application10.1038/s41413-024-00376-y ↗
28. Clinical-grade iPSC-derived chondrogenic micropellets for treating advanced cartilage defects10.1126/sciadv.adw4911 ↗
29. Single BMSC-derived cartilage organoids for gradient heterogeneous osteochondral regeneration by leveraging native vascular microenvironment10.1186/s12951-025-03403-0 ↗
30. Engineered human osteoarthritic cartilage organoids10.1016/j.biomaterials.2024.122549 ↗
31. Cartilage organoids bridging bench to bedside: a steroid-free strategy for early osteoarthritis repair
32. Cartilage organoids: an emerging platform for novel osteoarthritis therapies10.3389/fcell.2025.1668766 ↗
33. Cell surface markers of mesenchymal stem cells: current knowledge and advances in characterization technologies10.3390/life16010010 ↗
34. The chemokine SDF-1/CXCL12 contributes to the 'homing' of umbilical cord blood cells to a hypoxic-ischemic lesion in the rat brain10.1002/jnr.22292 ↗
35. CXCL12/CXCR4 axis promotes the chemotaxis and phagocytosis of B cells through the PI3K-AKT signaling pathway in an early vertebrate10.4049/jimmunol.2300562 ↗
36. The roles of Integrin α5β1 in human cancer10.2147/OTT.S273803 ↗
37. Visual histological grading system for the evaluation of in vitro-generated neocartilage10.1089/ten.2006.12.2141 ↗
38. A cytokine-induced spheroid-based in vitro model for studying osteoarthritis pathogenesis10.3389/fbioe.2023.1167623 ↗
39. Engineered nasal cartilage for the repair of osteoarthritic knee cartilage defects10.1126/scitranslmed.aaz4499 ↗
40. Enhanced bone regeneration via endochondral ossification using Exendin-4-modified mesenchymal stem cells
41. Engineering of a functional bone organ through endochondral ossification10.1073/pnas.1220108110 ↗
42. NF-κB signaling pathways in osteoarthritic cartilage destruction10.3390/cells8070734 ↗
43. Osteoarthritis: pathogenic signaling pathways and therapeutic targets10.1038/s41392-023-01330-w ↗
44. Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: inhibition of Smad1/5/8P prevents terminal differentiation and calcification10.1089/ten.tea.2010.0043 ↗
45. The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease10.1038/s41422-023-00918-9 ↗
46. Roles of matrix metalloproteinases and their natural inhibitors in metabolism: insights into health and disease10.3390/ijms241310649 ↗
47. A human organoid drug screen identifies α2-adrenergic receptor signaling as a therapeutic target for cartilage regeneration10.1016/j.stem.2024.09.001 ↗
48. Large-scale multicenter study reveals anticitrullinated SR-A peptide antibody as a biomarker and exacerbator for rheumatoid arthritis10.1126/sciadv.adr8078 ↗
49. Rational design matrix materials for organoid development and application in biomedicine10.1093/rb/rbaf038 ↗
50. Cartilage organoids for cartilage development and cartilage-associated disease modeling10.3389/fcell.2023.1125405 ↗
51. In situ remodeling of efferocytosis via lesion-localized microspheres to reverse cartilage senescence
52. Clinical phenotypes, molecular endotypes and theratypes in OA therapeutic development10.1038/s41584-024-01126-4 ↗
53. Identification of transcription factors responsible for dysregulated networks in human osteoarthritis cartilage by global gene expression analysis10.1016/j.joca.2018.07.012 ↗
54. Translational genomics of osteoarthritis in 1,962,069 individuals10.1038/s41586-025-08771-z ↗
55. Single-cell transcriptomics reveals novel chondrocyte and osteoblast subtypes and their role in knee osteoarthritis pathogenesis10.1038/s41392-025-02136-8 ↗
56. The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis
57. Regulation of matrix metalloproteinases: an overview10.1023/A:1026028303196 ↗
58. Recent advances in osteoarthritis research: a review of treatment strategies, mechanistic insights, and acupuncture
59. Anti-inflammatory and immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages10.1186/s12951-021-01236-1 ↗
60. Chondrogenic commitment of human umbilical cord blood and umbilical cord-derived mesenchymal stem cells induced by the supernatant of chondrocytes: a comparison study10.1002/ame2.12515 ↗
61. Single-cell transcriptome analysis of uncultured human umbilical cord mesenchymal stem cells10.1186/s13287-020-02055-1 ↗
62. Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products10.1186/s13287-021-02222-y ↗
63. Umbilical cord-derived stem cells for the treatment of knee osteoarthritis: a systematic review
64. Human umbilical cord mesenchymal stem cells promoting knee joint chondrogenesis for the treatment of knee osteoarthritis: a systematic review10.1186/s13018-023-04131-7 ↗
65. PTHrP targets HDAC4 and HDAC5 to repress chondrocyte hypertrophy10.1172/jci.insight.97903 ↗
66. Inhibitory function of parathyroid hormone-related protein on chondrocyte hypertrophy: the implication for articular cartilage repair10.1186/ar4025 ↗
67. An injectable liposome-anchored teriparatide incorporated gallic acid-grafted gelatin hydrogel for osteoarthritis treatment10.1038/s41467-023-38597-0 ↗
68. MMP13-targeted siRNA-loaded micelles for diagnosis and treatment of posttraumatic osteoarthritis
69. A roadmap of In vitro models in osteoarthritis: a focus on their biological relevance in regenerative medicine10.3390/jcm10091920 ↗
70. Recapitulation of cartilage/bone formation using iPSCs via biomimetic 3D rotary culture approach for developmental engineering10.1016/j.biomaterials.2020.120334 ↗
71. Synergistic promotion of bone regeneration through co-culture of endothelial cells with mesenchymal stem cells in endochondral ossification organoids10.1186/s13287-025-04733-4 ↗
72. In vitro inflammatory multi-cellular model of osteoarthritis10.1016/j.ocarto.2023.100432 ↗
73. Chondrocyte membrane-coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis10.1126/scitranslmed.adh9751 ↗
74. Establishment of an Ex vivo inflammatory osteoarthritis model with human osteochondral explants10.3389/fbioe.2021.787020 ↗
75. The physiological metabolite α-ketoglutarate ameliorates osteoarthritis by regulating mitophagy and oxidative stress10.1016/j.redox.2023.102663 ↗